Clinical Trials › NCT06529406
RecruitingPhase 4
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Sponsored by University of Colorado, Denver
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 100
Target enrollment
3
U.S. states
Jul 2024
Start date
Aug 2029
Expected completion
Interventions / Treatments
Ozanimod
Conditions studied
Relapsing Multiple Sclerosis
Participating MS centers on MS Buddy (2)
Mellen Center for MS Treatment & Research
Cleveland, OH
Cleveland, OH
MS centers in Colorado
Compare treatment centers near a trial site by center type, providers and trials.
View Colorado centersMore Phase 4 trials
Browse all Phase 4 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.